Xingtai Jiachuang Technology
Finnrick has tested 63 samples from Xingtai Jiachuang Technology across 4 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| GHK-Cu | 6 | 2 Mar 2026 | 13 Aug 2026 | |||||
| Retatrutide | 18 | 4 Jul 2025 | 15 Aug 2026 | |||||
| Tesamorelin | 11 | 4 Nov 2025 | 13 Aug 2026 | |||||
| Tirzepatide | 28 | 8 Jul 2025 | 20 Jul 2026 | |||||
The Xingtai Jiachuang Technology samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 25 overall satisfaction reports
People who submitted test requests to Finnrick gave Xingtai Jiachuang Technology an average satisfaction rating of 4.5 out of 5 across 25 reports associated with samples received and tested by Finnrick. Customers rated delivery speed (4.0/5) comparatively lower.
Most recent Xingtai Jiachuang Technology tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 15 Aug 2026 | Retatrutide | View | 10mg | 9.8mg | -2.0% | 99.80% | n/a | 05252026 | No Label / Silver Crimp / Clear Blue Cap | Lab G | Public | |
| 13 Aug 2026 | GHK-Cu | View | 100mg | 100mg | 99.70% | n/a | CX200601 | No label, Silver crimp, Blue cap | Lab G | Public | ||
| 13 Aug 2026 | Retatrutide | View | 10mg | 10.2mg | +2.0% | 99.70% | n/a | Jun 23, 2026 | No label, Copper crimp, Clear cap | Lab G | Public | |
| 13 Aug 2026 | Tesamorelin | View | 10mg | 10.6mg | +6.0% | 99.70% | n/a | LX260514 | No label, Silver crimp, Black cap | Lab G | Public | |
| 3 Aug 2026 | GHK-Cu | View | 100mg | 64.6mg | -35.4% | 99.90% | n/a | 03152026 | No label / Silver crimp / Violet cap | Lab E | Public | |
| 20 Jul 2026 | Tirzepatide | View | 30mg | 27.4mg | -8.7% | 99.80% | low | (no batch ID) | No label / Silver crimp / Black cap | Lab E | Public | |
| 20 Jul 2026 | GHK-Cu | View | 100mg | 90.6mg | -9.4% | 99.90% | not detected | (no batch ID) | No label / Silver crimp / Violet cap | Lab E | Public | |
Corrections
- 26 Jul 2026: Tirzepatide
- The reported value of 15 mg was inadvertently carried over from a previous Certificate of Analysis (COA) associated with a different sample. This value did not correspond to sample 7f5fe47 and was included in error. The incorrect information has been removed, and the system has been updated to correctly reference the original label claim of 60 mg for this sample.
About Xingtai Jiachuang Technology Test Results From Finnrick
Xingtai Jiachuang Technology is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 4 products and 63 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Xingtai Jiachuang Technology Testing Activity & Score Summary
In the past 30 days, Finnrick has published 5 new test results for Xingtai Jiachuang Technology, and 19 in the past three months. The overall dataset includes 63 tested samples with an average score of 6.7/10 across all products.
Across 63 identity-tested samples, 90% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.8%. Approximately 98% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Tirzepatide (28 tests, 93% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 0.0 to 10.0 (average 6.7/10), suggesting significant batch-to-batch differences.
- Retatrutide (18 tests, 83% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 0.0 to 10.0 (average 6.7/10), suggesting significant batch-to-batch differences.
- GHK-Cu (6 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 6.5 to 10.0 (average 7.8/10), suggesting significant batch-to-batch differences.